Barney Scholefield
Hospital Positions
Director of Neurocritical Care
Biography
Dr. Barney Scholefield joined The Hospital for Sick Children (SickKids) in 2023 in the Department of Critical Care Medicine, Division of Paediatric Intensive Care. He had been appointed as Director of Neurocritical care and leads the Team Brain: clinical, academic and educational programme. Scholefield was previously a Consultant and NIHR Clinician Scientist at the Birmingham Women and Children's NHS Foundation Trust, UK and the University of Birmingham, 2012 to 2023.
Research
Scholefield leads two major fields of paediatric critical care research:
- Neurological prognosis and uncertainty after cardiac arrest in children
- Implementation of early rehabilitation and mobilisation in critical care
His broader research interest include delivery of pragmatic clinical trials, neuromonitoring & neuroprotection, and evidence evaluation and implementation into clinical practice guidelines. Scholefield's ambition is to improve the care provided to critically unwell and injured children and adults by pushing the boundaries in critical care research, leading the delivery of high-quality clinical care, imparting that knowledge through innovative education and breaking down traditional barriers. Collaborative work, ‘team science’ and shared visions are essential principles in achieving this.
Education and experience
- 2023: Staff Physician in Paediatric Intensive Care Medicine, The Hospital for Sick Children, Toronto, ON, Canada
- 2017–2023: NIHR Clinician Scientist & Associate Professor, University of Birmingham, UK
- 2012–2023: Consultant in Paediatric Intensive Care Medicine, Birmingham Women’s & Children’s NHS Foundation Trust, UK
- 2013: PhD, Doctor of Philosophy, Warwick University, UK
- 2012: Certificate of Completion of Training, General Medical Council Specialist Register - Paediatrics (Paediatric Intensive Care)
- 2010: M.Sc., Master of Science in Critical Care, Cardiff University, UK
- 2007–2012: Higher specialist training in Paediatric Intensive Care Medicine, Birmingham Women’s & Children’s NHS Foundation Trust, UK
- 2004–2007: Specialist Registrar (Paediatric & Neonatology), West Midlands, UK
- 2003: MRCPCH, Membership of the Royal College of Paediatrics and Child Health, London UK
- 2001–2004: Senior House Officer (Paediatric & Neonatology), West Midlands, UK
- 2000–2001: House officer (Paediatrics, Cardiology and Surgery) University Hospital Lewisham, UK
- 2000: MBBS, Guy's, Kings and St Thomas, London, UK
- 1997: B.Sc., Clinical Anatomy, University of London, UK
Achievements
- 2023: National Clinical Impact Award (Level N2), NHS, UK
- 2021: Director of Birmingham Acute Care Research Group, University of Birmingham
- 2021: Appointed Vice Chair Pediatric Life Support Task Force, International Liaison Committee on Resuscitation
- 2021: Winner UK Clinical Research Network Principal Investigator Award
- 2017: Elected Chair of the Neuro-critical Care section of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC)
- 2017: Elected Chair of Paediatric Critical Care Society – Study Group, UK
- 2017: BCH Annual Star Award Winner for Outstanding Personal Contribution to Charity
- 2017: National Institute for Health Research (NIHR) Clinician Scientist Advanced Fellowship award, NIHR, UK
- 2015 & 2018: Local Clinical Excellence Awards (x2) NHS Consultant award
Publications
- Scholefield BR, Menzies JC, McAnuff J, Thompson JY, Manning JC, Feltbower RG, Geary M, Lockley S, Morris KP, Moore D, Pathan
N, Kirkham F, Forsyth R, Rapley T. Implementing early rehabilitation and mobilisation for children in UK paediatric intensive care units: the PERMIT feasibility study. Health Technol Assess. 2023 Nov;27(27):1-155. doi: 10.3310/HYRW5688. PubMed PMID: 38063184. - Davies P, Evans C, Kanthimathinathan HK, Lillie J, Brierley J, Waters G, Johnson M, Griffiths B, du Pre P, Mohammad Z, Deep A,
Playfor S, Singh D, Inwald D, Jardine M, Ross O, Shetty N, Worrall M, Sinha R, Koul A, Whittaker E, Vyas H, Scholefield BR*,
Ramnarayan P. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. Lancet Child Adolesc Health. 2020;4(9):669-77. - Moler FW, Silverstein FS, Holubkov R, Slomine BS, Christensen JR, Nadkarni VM, Meert KL, Browning B, Pemberton VL, Page K,
Gildea MR, Scholefield BR, Shankaran S, Hutchison JS, Berger JT, Ofori-Amanfo G, Newth CJ, Topjian A, Bennett KS, Koch JD, Pham
N, Chanani NK, Pineda JA, Harrison R, Dalton HJ, Alten J, Schleien CL, Goodman DM, Zimmerman JJ, Bhalala US, Schwarz AJ, Porter
MB, Shah S, Fink EL, McQuillen P, Wu T, Skellett S, Thomas NJ, Nowak JE, Baines PB, Pappachan J, Mathur M, Lloyd E, van der Jagt
EW, Dobyns EL, Meyer MT, Sanders RC, Jr., Clark AE, Dean JM. Therapeutic Hypothermia after In-Hospital Cardiac Arrest in Children.
N Engl J Med. 2017;376(4):318-29. - Scholefield BR, Silverstein FS, Telford R, Holubkov R, Slomine BS, Meert KL, Christensen JR, Nadkarni VM, Dean JM, Moler FW.
Therapeutic hypothermia after paediatric cardiac arrest: Pooled randomized controlled trials. Resuscitation. 2018;133:101-7. - Ramcharan T, Nolan O, Lai CY, Prabhu N, Krishnamurthy R, Richter AG, Jyothish D, Kanthimathinathan HK, Welch SB, Hackett S,
Al-Abadi E, Scholefield BR*, Chikermane A. Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital. Pediatr Cardiol. 2020;41
(7):1391-401.
- 2020–present: NIHR128895 - Evaluating the clinical and cost effectiveness of using a more permissive blood pressure target to guide careful titration of vasoactive agents in critically ill children with hypotension: PRotocolised Evaluation of permiSSive blood pressure targets versus Usual caRE (PRESSURE). Role: Co-applicant (3%) NIHR HTA NIHR128895. £1.7M (CA$2.89M)
- 2020–present: Del Nido versus St Thomas’ blood cardioplegia: A multi-centre randomised controlled trial in children undergoing cardiac surgery. British Heart Foundation (CS/20/3/34738). Role: Co-applicant (3%). £560,000 (CA$950,000)
- 2020–present: PRP (28-02-01) Evaluation of ICON to prevent instances of Abusive Head Trauma (AHT) in infants.
- 2020: NIHR – named collaborator. £229,000 (CA$389,000)
- 2018–2023: Paediatric Early Rehabilitation and Mobilisation during InTensive Care (PERMIT) feasibility study – NIHR HTA. Understanding, developing and implementing an early rehabilitation and mobilisation programme. Multi-centre, 4 phase, mixed method study with 6 collaborating Universities and 14 PICUs across NHS. Role: Chief Investigator 20%. £420,000 (CA$714,000)
- 2017–2022: NIHR Clinician Scientist Award (NIHR CS-2016-15-016) – NEURO-PACK programme (NEUROlogical Prognosis After Cardiac arrest in Kids). Development of a clinical prediction models for prognostication after cardiac arrest, uncertainty research and targeted temperature management post-cardiac arrest therapy evaluation. Ongoing publications with planned direct impact via Resuscitation council guidance on post-arrest care. Role: Chief Investigator 60%. £1.2M (CA$2.04M)